Ocatarine is a synthetic biology company developing superior cannabinoid and psilocybin derivatives.

Octarine harnesses synthetic biology to develop functionally superior cannabinoid and psilocybin derivatives.
Our mission is to improve the health and well-being of people worldwide

Using our unique biosynthetic platform we engineer microorganisms to produce a range of natural and novel cannabinoid and psilocybin derived molecules with improved pharmacokinetic and therapeutic properties.

We make super molecules! Improving on what nature already offers in ways that aren’t feasible with traditional organic chemistry. We have developed proprietary enzyme platform technologies to efficiently modify molecules, and fermentation platforms to effectively scale-up production.

Recent News


private company